Study Stopped
pandemic situation
Comparison of Mortality Impact of Coagulation Rotative Thromboelastometry Analysis Versus Standard Analysis
HD-ROTEM
1 other identifier
interventional
13
1 country
1
Brief Summary
Digestive hemorrhage is a common cause of acute hemorrhage in France, and its mortality remains high despite improvement of endoscopy technique and therapeutics. Hemostasis disorders are an important issue in the patient care both in severity diagnostic and therapeutic plan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2018
CompletedFirst Submitted
Initial submission to the registry
October 9, 2018
CompletedFirst Posted
Study publicly available on registry
October 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2020
CompletedNovember 30, 2021
January 1, 2021
1.8 years
October 9, 2018
November 29, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
28-day mortality rate
day 28
Secondary Outcomes (3)
Fresh-frozen plasma
day 2
Length of stay
day 28
Recurrent bleeding
Day 2
Study Arms (1)
Rotative thromboelastometry analysis
EXPERIMENTALEvaluation of diagnostic properties of coagulation by rotative thromboelastometry in patient with digestive hemorrhage in predictive value of mortality.
Interventions
Obtaining blood sample (one tube of blood)
Eligibility Criteria
You may qualify if:
- Hospitalized patient in reanimation unit or continuous monitoring for digestive hemorrhage before or immediately after digestive endoscopy
- Digestive hemorrhage diagnostic: melena and/or rectal bleeding and/or hematemesis
- Affiliation to the social security
- Have signed an informed consent
You may not qualify if:
- Pregnant or nursing woman
- Without digestive fibroscopy
- With an anticoagulant treatment
- With a congenital coagulopathy
- Decision of therapeutic limitation or moribund patient
- With a digestive hemorrhage after an hospitalisation in reanimation unit for an other reason
- Participation in an other study in previous 30 days
- Under trusteeship, guardianship or judicial safeguards
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHR Metz Thionville
Metz, 57085, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2018
First Posted
October 11, 2018
Study Start
October 8, 2018
Primary Completion
August 8, 2020
Study Completion
August 21, 2020
Last Updated
November 30, 2021
Record last verified: 2021-01